购物车
- 全部删除
- 您的购物车当前为空
GSK180 is a selective competitive inhibitor of kynurenine 3-monooxygenase (KMO; IC50: ~6 nM), an enzyme involved in tryptophan metabolism.
为众多的药物研发团队赋能,
让新药发现更简单!
GSK180 is a selective competitive inhibitor of kynurenine 3-monooxygenase (KMO; IC50: ~6 nM), an enzyme involved in tryptophan metabolism.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 740 | 5日内发货 | |
5 mg | ¥ 1,230 | 5日内发货 | |
25 mg | ¥ 4,480 | 6-8周 | |
50 mg | ¥ 5,820 | 6-8周 | |
100 mg | ¥ 8,730 | 6-8周 | |
1 mL x 10 mM (in DMSO) | ¥ 1,370 | 5日内发货 |
产品描述 | GSK180 is a selective competitive inhibitor of kynurenine 3-monooxygenase (KMO; IC50: ~6 nM), an enzyme involved in tryptophan metabolism. |
靶点活性 | KMO:~6 nM |
体外活性 | GSK180 inhibits endogenous KMO activity in primary human hepatocytes (IC50=2.6 μM) and it also inhibits rat KMO slightly less potently than the human enzyme (IC50=7 μM). |
体内活性 | GSK180 is fit for i.v. management [1]. |
分子量 | 276.07 |
分子式 | C10H7Cl2NO4 |
CAS No. | 1799725-26-0 |
密度 | 1.626 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容